https://www.indianpharmapost.com/roche-closes-acquisition-of-lumiradxs-point-of-care-technology-159732024-08-05T00:00:00+05:30always0.9https://www.indianpharmapost.com/divis-laboratories-reports-q1-fy25-consolidated-pat-at-rs-430-cr-159742024-08-05T00:00:00+05:30always0.9https://www.indianpharmapost.com/finerenone-meets-primary-endpoint-in-phase-iii-finearts-hf-cardiovascular-study-159752024-08-05T00:00:00+05:30always0.9